Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kanbis (Cannabidiol) for Parkinson's Disease Symptoms
NCT06629389Phase 2Recruiting
- Sponsor
- Laboratorio Elea Phoenix S.A.
- Start
- Nov 2024
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol in Parkinson's disease (PD), sponsored by Laboratorio Elea Phoenix S.A.. Started Nov 2024; status: recruiting.
02
Drugs
cannabidiol
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT06629389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06629389.